Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
2seventy Bio, Inc. (TSVT)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 51,961,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   2seventy bio is a cell and gene therapy company focused on the research, development, and commercialization of treatments for cancer. Co.'s approach combines its capability in T cell engineering technology and lentiviral vector gene delivery approaches, experience in research, development, and manufacturing of cell therapies and a suite of technologies that can be selectively deployed to develop targeted cellular therapies for patients with cancer. Co. is developing various preclinical and clinical programs in oncology and, together with its partner Bristol-Myers Squibb, delivering idecabtagene vicleucel to multiple myeloma patients in the U.S. following approval by the FDA.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 817,377 817,377 2,021,033 2,021,033
Total Buy Value $4,103,042 $4,103,042 $11,231,670 $11,231,670
Total People Bought 2 2 4 4
Total Buy Transactions 4 4 8 8
Total Shares Sold 0 135,305 177,739 231,785
Total Sell Value $0 $522,999 $768,554 $1,472,712
Total People Sold 0 3 3 4
Total Sell Transactions 0 6 12 31
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 85
  Page 3 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baird William D Iii Chief Financial Officer   •       –      –    2023-01-11 4 S $10.63 $11,446 D/D (1,077) 78,797     -
   Leschly Nick President and CEO   •       •      –    2023-01-11 4 S $10.63 $21,533 D/D (2,026) 534,393     -
   Baird William D Iii Chief Financial Officer   •       –      –    2023-01-09 4 S $10.33 $33,298 D/D (3,222) 79,874     -
   Heffron Nicola Chief Operating Officer   •       –      –    2023-01-09 4 S $10.33 $6,035 D/D (584) 89,370     -
   Leschly Nick President and CEO   •       •      –    2023-01-09 4 S $10.33 $30,787 D/D (2,979) 543,006     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2023-01-09 4 S $10.33 $39,210 D/D (3,794) 100,594     -
   Heffron Nicola Chief Operating Officer   •       –      –    2022-12-05 4 S $15.43 $4,198 D/D (272) 89,954     -
   Heffron Nicola Chief Operating Officer   •       –      –    2022-11-21 4 S $13.97 $107,527 D/D (7,697) 90,226     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2022-08-05 4 S $16.23 $39,072 D/D (2,407) 104,388     -
   Baird William D Iii Chief Financial Officer   •       –      –    2022-08-05 4 S $16.23 $67,397 D/D (4,152) 83,096     -
   Leschly Nick President and CEO   •       •      –    2022-08-05 4 S $16.23 $89,263 D/D (5,499) 545,985     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2022-07-15 4 S $13.81 $32,660 D/D (2,365) 106,795     -
   Leschly Nick President and CEO   •       •      –    2022-07-15 4 S $13.81 $74,629 D/D (5,404) 551,484     -
   Baird William D Iii Chief Financial Officer   •       –      –    2022-07-15 4 S $13.81 $56,344 D/D (4,080) 87,248     -
   Leschly Nick President and CEO   •       •      –    2022-03-17 4/A B $12.20 $4,500,055 D/D 368,857 556,888 0.01     -
   Leschly Nick President and CEO   •       •      –    2022-03-17 4 A $12.20 $4,500,055 D/D 368,857 556,888     -
   Baird William D Iii Chief Financial Officer   •       –      –    2022-03-01 4 A $0.00 $0 D/D 33,750 91,328     -
   Heffron Nicola Chief Operating Officer   •       –      –    2022-03-01 4 A $0.00 $0 D/D 42,500 97,923     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2022-03-01 4 A $0.00 $0 D/D 47,500 109,160     -
   Leschly Nick President and CEO   •       •      –    2022-03-01 4 A $0.00 $0 D/D 133,500 690,388     -
   Baird William D Iii Chief Financial Officer   •       –      –    2022-02-17 4 S $14.78 $6,311 D/D (427) 57,578     -
   Heffron Nicola Chief Operating Officer   •       –      –    2022-02-07 4 S $16.01 $26,194 D/D (1,636) 55,423     -
   Heffron Nicola Chief Operating Officer   •       –      –    2022-02-04 4 S $15.41 $7,198 D/D (467) 57,059     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2022-01-07 4 S $23.91 $34,714 D/D (1,452) 61,660     -
   Leschly Nick President and CEO   •       •      –    2022-01-07 4 S $23.91 $78,179 D/D (3,270) 188,031     -
  85 Records found
  1  2  3  4   
  Page 3 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us